Dranoff, Glenn
Dana-Farber Cancer Institute,
United States
2025 Rank: 25049
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 498 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25049 | 28567 |
| Total Cites | 1452 | 1496 |
| H-index | 17 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 85 | 85 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 657 | 670 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1330 | 1354 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.10 |
| Self-Citation Percentage |
2.94%
|
|
Dranoff, Glenn
Novartis Biomedical Research,
United States
2024 Rank: 30638
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 647 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30638 | 33407 |
| Total Cites | 1215 | 1260 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 70 | 70 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 600 | 614 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1120 | 1151 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
3.57%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2023 Rank: 22553
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 530 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22553 | 25573 |
| Total Cites | 1391 | 1446 |
| H-index | 19 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 84 | 84 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 671 | 690 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1255 | 1286 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
3.80%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2022 Rank: 18179
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 505 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18179 | 20359 |
| Total Cites | 1487 | 1538 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 35 | 35 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 102 | 102 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 731 | 734 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1337 | 1377 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.12 |
| Self-Citation Percentage |
3.32%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2021 Rank: 14430
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 367 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14430 | 16476 |
| Total Cites | 2289 | 2374 |
| H-index | 24 | 24 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 61 | 61 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 167 | 167 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 1160 | 1166 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2029 | 2090 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
3.58%
|
|
Dranoff, Glenn
Novartis Institutes for BioMedical Research, Inc.,
United States
2020 Rank: 16101
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 375 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16101 | 17273 |
| Total Cites | 1854 | 1944 |
| H-index | 21 | 23 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 32 | 32 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 115 | 116 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 875 | 897 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1641 | 1700 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
4.63%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.